America Great Health (AAGH)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jun 16, 2026, 4:00 PM EST
America Great Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 0.44 | 0.39 | 0.29 | 0.2 | 0.1 | 0.2 |
| 0.44 | 0.39 | 0.29 | 0.2 | 0.1 | 0.2 | |
Revenue Growth (YoY) | 4.32% | 32.94% | 44.23% | 95.23% | -46.52% | 3474.55% |
Cost of Revenue | 0.12 | 0.05 | 0.12 | 0.04 | 1.59 | 0.14 |
Gross Profit | 0.32 | 0.34 | 0.17 | 0.17 | -1.48 | 0.05 |
Selling, General & Admin | 0.64 | 0.72 | 0.95 | 0.66 | 3.25 | 0.29 |
Operating Expenses | 0.64 | 0.72 | 0.95 | 0.66 | 3.25 | 0.29 |
Operating Income | -0.32 | -0.38 | -0.78 | -0.49 | -4.73 | -0.24 |
Interest Expense | -0.34 | -0.34 | -0.44 | -0.32 | -0.19 | -0.02 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | - |
Earnings From Equity Investments | - | - | - | - | - | -0.01 |
Other Non Operating Income (Expenses) | - | - | - | 0.03 | 0 | - |
EBT Excluding Unusual Items | -0.66 | -0.72 | -1.23 | -0.78 | -4.92 | -0.27 |
Pretax Income | -0.66 | -0.72 | -1.23 | -0.78 | -4.92 | -0.27 |
Earnings From Continuing Operations | -0.66 | -0.72 | -1.23 | -0.78 | -4.92 | -0.27 |
Net Income to Company | -0.66 | -0.72 | -1.23 | -0.78 | -4.92 | -0.27 |
Minority Interest in Earnings | 0 | 0 | 0.01 | 0.02 | 0.06 | - |
Net Income | -0.66 | -0.72 | -1.22 | -0.76 | -4.87 | -0.27 |
Net Income to Common | -0.66 | -0.72 | -1.22 | -0.76 | -4.87 | -0.27 |
Shares Outstanding (Basic) | 21,148 | 21,144 | 21,123 | 21,093 | 21,090 | 20,439 |
Shares Outstanding (Diluted) | 21,148 | 21,144 | 21,123 | 21,093 | 21,090 | 20,439 |
Shares Change (YoY) | 0.07% | 0.10% | 0.14% | 0.02% | 3.19% | 1.00% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Free Cash Flow | -0.19 | -0.33 | -0.62 | -0.43 | -1.5 | -0.34 |
Gross Margin | 73.55% | 86.57% | 57.61% | 82.52% | - | 26.25% |
Operating Margin | -71.83% | -97.75% | -265.62% | -241.13% | -4523.83% | -124.47% |
Profit Margin | -150.07% | -183.57% | -414.22% | -372.68% | -4650.02% | -137.50% |
Free Cash Flow Margin | -43.90% | -84.97% | -208.92% | -212.54% | -1430.23% | -174.74% |
EBITDA | -0.3 | -0.37 | -0.77 | -0.48 | -4.73 | - |
EBITDA Margin | -68.46% | -93.98% | -260.60% | -236.06% | - | - |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - |
EBIT | -0.32 | -0.38 | -0.78 | -0.49 | -4.73 | -0.24 |
EBIT Margin | -71.83% | -97.75% | -265.62% | -241.13% | - | -124.47% |